BREAKING

Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago

ADVERTISEMENT

AlphaGraphs

Infographic: Highlights of Aurora Cannabis (ACB) Q2 2021 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a loss for the second quarter of 2021, continuing the recent trend. However, the bottom-line performance improved from the year-ago period. The Canada-based medical marijuana company said its loss from continuing operations narrowed to C$292.8 million in the December quarter from C$1.30 billion in the second quarter […]

$ACB February 12, 2021 1 min read

NYSE

$ACB · Earnings

“
Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a loss for the second quarter of 2021, continuing the recent trend. However, the bottom-line performance improved from the year-ago period. The Canada-based medical marijuana company said its loss from continuing operations narrowed to C$292.8 million in the December quarter from C$1.30 billion in the second quarter […]
· February 12, 2021

Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a loss for the second quarter of 2021, continuing the recent trend. However, the bottom-line performance improved from the year-ago period.

Aurora Cannabis Q2 2021 earnings infographic

The Canada-based medical marijuana company said its loss from continuing operations narrowed to C$292.8 million in the December quarter from C$1.30 billion in the second quarter of 2020. The improvement reflects a 23% year-over-year increase in revenues to C$67.67 million.

Read management/analysts’ comments on Aurora’s Q1 results

Shares of Aurora Cannabis declined soon after the earnings release on Thursday evening at the New York Stock Exchange, after closing the session down 23%.

ADVERTISEMENT

ADVERTISEMENT